Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia.
Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, NSW, 2006, Australia; Australian Research Centre of Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Australia.
Complement Ther Med. 2018 Dec;41:52-60. doi: 10.1016/j.ctim.2018.08.016. Epub 2018 Sep 4.
To report the prevalence and sociodemographic characteristics of complementary medicine (CM) use by Australian and American adults living with gastrointestinal (GI) disorders.
Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase, Medline, Pubmed, Scopus and Web of Science were searched for studies published in English language between 1 January 2008 and 8 April 2018. Additionally, a Google Scholar search and risk of bias assessment were conducted.
Twelve (five American and seven Australian) studies, involving 53,991 adults were included. Data were extracted from studies reporting CM use by both specific populations with medically diagnosed GI disorders and the general population with self-reported GI disorders. CM use ranged from 23.6% to 44% (American) and 27.2% to 58% (Australian) by adults with medically diagnosed GI disorders. Whilst CM use was higher amongst females, with higher incomes and education levels. The prevalence of CM use by those with self-reported GI disorders varied from 0.31% to 80%. Herbal, probiotic supplements and mind-body practices were the most prevalent CMs used. The risk of bias assessment identified weaknesses in the external validity, principally related to poor study design.
There is a substantial use of CMs by American and Australian adults with GI disorders. Females with higher education and income are predominant users. There is a need to conduct up-to-date and well-designed prevalence and sociodemographic studies. Additionally, future studies should consider including health literacy and medicines disclosure scales in order to better understand CM use by this population.
报告澳大利亚和美国患有胃肠道（GI）疾病的成年人使用补充医学（CM）的流行率和社会人口学特征。
检索 Cumulative Index to Nursing and Allied Health Literature（CINAHL）、Embase、Medline、Pubmed、Scopus 和 Web of Science 数据库，检索时间为 2008 年 1 月 1 日至 2018 年 4 月 8 日，期间发表的英文文献。此外，还进行了 Google Scholar 搜索和偏倚风险评估。
纳入了 12 项（5 项来自美国，7 项来自澳大利亚）研究，共涉及 53991 名成年人。数据来自于报告特定人群（经医学诊断患有 GI 疾病的人群）和一般人群（自我报告患有 GI 疾病的人群）中 CM 使用情况的研究。经医学诊断患有 GI 疾病的成年人中，CM 使用范围为 23.6%至 44%（美国）和 27.2%至 58%（澳大利亚）。CM 使用情况在女性、高收入和高教育程度人群中更高。自我报告患有 GI 疾病的人群中，CM 使用的流行率从 0.31%至 80%不等。草药、益生菌补充剂和身心实践是最常用的 CM。偏倚风险评估发现，研究设计不佳，主要是外部有效性存在缺陷。
美国和澳大利亚患有 GI 疾病的成年人大量使用 CM。女性、高教育和高收入人群是主要使用者。需要进行最新的、设计良好的流行率和社会人口学研究。此外，未来的研究应考虑纳入健康素养和药物披露量表，以便更好地了解这一人群对 CM 的使用情况。
